Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Goupille

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Rheumatology International|June 14, 2021
Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseasesGermano Vera Cruz, Emilie Bucourt, Christian Réveillère, et al.
Pain Medicine (Malden, Mass.)|November 12, 2019
A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren's Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping StrategiesEmilie Bucourt, Virginie Martaillé, Philippe Goupille, et al.
Arthritis Research & Therapy|June 29, 2011
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseasesEmilie Ducourau, Denis Mulleman, Gilles Paintaud, et al.
Clinical Pharmacokinetics|December 14, 2017
Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough ConcentrationDavid Ternant, Christophe Passot, Alexandre Aubourg, et al.
The Journal of Rheumatology|August 23, 2006
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritisJean-David Cohen, Maxime Dougados, Philippe Goupille, et al.
RMD Open|November 18, 2021
Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trialsJohan Law-Wan, Marc-Antoine Sparfel, Sophie Derolez, et al.
Therapeutic Drug Monitoring|July 12, 2011
Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label studyJean-Camille Méric, Denis Mulleman, Emilie Ducourau, et al.
Joint Bone Spine|December 14, 2004
Patient knowledge of their disease: a French multicenter study in ankylosing spondylitisPascal Claudepierre, René-Marc Flipo, Jean Sibilia, et al.
Clinical and Experimental Rheumatology|December 22, 2021
Real-life golimumab persitence in patients with axial spondyloarthritis: post-hoc results of the prospective observational cohort study, GO-PRACTICEPhilippe Goupille, Philippe Bertin, Florence Tubach, et al.
Rheumatology (Oxford, England)|April 25, 2023
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED studyGurjit S Kaeley, Georg Schett, Philip G Conaghan, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Rheumatology International|June 14, 2021
Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseasesGermano Vera Cruz, Emilie Bucourt, Christian Réveillère, et al.
Pain Medicine (Malden, Mass.)|November 12, 2019
A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren's Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping StrategiesEmilie Bucourt, Virginie Martaillé, Philippe Goupille, et al.
Arthritis Research & Therapy|June 29, 2011
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseasesEmilie Ducourau, Denis Mulleman, Gilles Paintaud, et al.
Clinical Pharmacokinetics|December 14, 2017
Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough ConcentrationDavid Ternant, Christophe Passot, Alexandre Aubourg, et al.
The Journal of Rheumatology|August 23, 2006
Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritisJean-David Cohen, Maxime Dougados, Philippe Goupille, et al.
RMD Open|November 18, 2021
Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trialsJohan Law-Wan, Marc-Antoine Sparfel, Sophie Derolez, et al.
Therapeutic Drug Monitoring|July 12, 2011
Therapeutic drug monitoring of infliximab in spondyloarthritis: an observational open-label studyJean-Camille Méric, Denis Mulleman, Emilie Ducourau, et al.
Joint Bone Spine|December 14, 2004
Patient knowledge of their disease: a French multicenter study in ankylosing spondylitisPascal Claudepierre, René-Marc Flipo, Jean Sibilia, et al.
Clinical and Experimental Rheumatology|December 22, 2021
Real-life golimumab persitence in patients with axial spondyloarthritis: post-hoc results of the prospective observational cohort study, GO-PRACTICEPhilippe Goupille, Philippe Bertin, Florence Tubach, et al.
Rheumatology (Oxford, England)|April 25, 2023
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED studyGurjit S Kaeley, Georg Schett, Philip G Conaghan, et al.
Pageof 13